J. Joseph et al., LINEAR ACCELERATOR-BASED STEREOTAXIC RADIOSURGERY FOR BRAIN METASTASES - THE INFLUENCE OF NUMBER OF LESIONS ON SURVIVAL, Journal of clinical oncology, 14(4), 1996, pp. 1085-1092
Purpose: To evaluate the influence of the number of brain metastases o
n survival after stereotaxic radiosurgery and factors that affect the
risk of delayed radiation necrosis after treatment. Materials and Meth
ods: Between March 1989 and December 1993, 120 consecutive patients un
derwent linear accelerator-based stereotaxic radiosurgery for brain me
tastases identified by computed tomography (CT) or magnetic resonance
image (MRI) scans, The influence of various clinical factors on outcom
e was assessed using Kaplan-Meier plots of survival from the date of r
adiosurgery, and univariate and multivariate analyses. Results: The me
dian survival time was 32 weeks, Progressive brain metastases, both lo
cal and regional, caused 25 of 104 deaths, Patients with two metastase
s (n = 30) or a solitary metastasis (n = 70) had equivalent actuarial
survival times (P = 0.7; median, 37 weeks; maximum, 211+ weeks), Patie
nts treated to three or more metastases (n = 20) had significantly sho
rter survival times (P < .002; median, 14 weeks; maximum, 63 weeks). P
rognostic factors associated with prolonged survival included a pretre
atment Karnofsky performance status greater than or equal to 70% and f
ewer than three metastases. Delayed radiation necrosis at the treated
site developed in 20 patients and correlated with prior or concurrent
delivery of whole-brain irradiation and the logarithm of the tumor vol
ume. Conclusion: Survival duration is equivalent for patients with one
or two brain metastases and is similar to that reported for patients
with a solitary metastasis managed by surgical resection and whole-bra
in irradiation. Survival after radiosurgery for three or more metastas
es was similar to that reported for whole-brain irradiation. (C) 1996
by American Society of Clinical Oncology.